12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

This study has been completed.

Study NCT00046150 Information provided by Sanofi-Aventis

First Received: September 20, 2002 Last Updated: June 18, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2002
Estimated Primary Completion Date:	No date given